Skip to main content
Journal cover image

PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials.

Publication ,  Conference
Choueiri, TK; Flaifel, A; Xie, W; Braun, D; Ficial, M; Jennings, R; Nassar, A; Escudier, B; George, DJ; Motzer, RJ; Morris, MJ; Powles, T ...
Published in: Ann Oncol
October 2018

Duke Scholars

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

October 2018

Volume

29 Suppl 8

Start / End Page

viii726

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Choueiri, T. K., Flaifel, A., Xie, W., Braun, D., Ficial, M., Jennings, R., … Signoretti, S. (2018). PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials. In Ann Oncol (Vol. 29 Suppl 8, p. viii726). England. https://doi.org/10.1093/annonc/mdy424.040
Choueiri, T. K., A. Flaifel, W. Xie, D. Braun, M. Ficial, R. Jennings, A. Nassar, et al. “PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials.” In Ann Oncol, 29 Suppl 8:viii726, 2018. https://doi.org/10.1093/annonc/mdy424.040.
Choueiri, T. K., et al. “PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials.Ann Oncol, vol. 29 Suppl 8, 2018, p. viii726. Pubmed, doi:10.1093/annonc/mdy424.040.
Choueiri TK, Flaifel A, Xie W, Braun D, Ficial M, Jennings R, Nassar A, Escudier B, George DJ, Motzer RJ, Morris MJ, Powles T, Wang E, Huang Y, Freeman G, Signoretti S. PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials. Ann Oncol. 2018. p. viii726.
Journal cover image

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

October 2018

Volume

29 Suppl 8

Start / End Page

viii726

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis